EORTC Highlights New Research on Immunogenic Effects of Radiotherapy in Cancer Care
European Organisation for Research and Treatment of Cancer (EORTC) shared a post on LinkedIn about a paper by Jonas Willmann et al. published in Radiotherapy and Oncology:
“Yesterday was World Radiotherapy Awareness Day, a moment to reflect on the impact of radiotherapy in cancer care.
To mark the occasion, we’re sharing a recent publication in Radiotherapy and Oncology that dives into how tumour irradiation can trigger immunogenic responses. A fascinating intersection of radiotherapy and immunotherapy.
It’s exciting to see how radiotherapy continues to evolve beyond local treatment into a key player in systemic cancer therapy.
Read the article.”
Title: Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedure
Authors: Jonas Willmann, Joost J.C. Verhoeff, Orit Kaidar-Person, André Abrunhosa-Branquinho, Enrico Clementel, Coreen Corning, Daniel Portik, Luiza Souza, Jaap C. Reijneveld, Frederic Dhermain, Coen Hurkmans, Angelo Filippo Monti, Jordi Saez, Warren P. Mason, Michael Weller, Patrick Roth, Nicolaus Andratschke
You can read the Full Article in Radiotherapy and Oncology.
More posts featuring EORTC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023